Commonwealth Medicine, Center for Health Policy and Research
Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Substance Abuse and Addiction
This presentation details the impact of state Medicaid programs placing lifetime limits on buprenorphine therapy for individuals with opioid dependence. The research reveals that setting limits does not save money or help the patient.
Opioid management, pharmacy, behavioral health, Medicaid, buprenorphine therapy, opioid dependence
DOI of Published Version
Commonwealth Medicine Publications
Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher WH. (2014). Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?. Commonwealth Medicine Publications. https://doi.org/10.13028/fn5e-vj16. Retrieved from https://escholarship.umassmed.edu/commed_pubs/98